Mars Names Carlos Andres-Luna Science Diagnostics President
The internal promotion from Royal Canin takes effect January 1, 2027, succeeding Katie Devine in the Mars Petcare division.
Updated on Nov. 19, 2026 in People

Mars has named Carlos Andres-Luna Global President of Science & Diagnostics, a division within Mars Petcare, succeeding Katie Devine, who has moved on from the company. Andres-Luna, previously Regional President for Rapid Growth Markets at Royal Canin, will start in the role on January 1, 2027.
Why it matters
The division oversees a portfolio that includes Antech veterinary diagnostics, Vetsource, and Wisdom Panel genomics testing, placing leadership continuity at the center of Mars Petcare's diagnostics strategy. Andres-Luna will report to Marc Carena, President of Mars Petcare.
Mars Petcare is a business of more than $30bn within a parent company with annual revenue above $65bn and roughly 170,000 associates worldwide. The announcement does not disclose the reasons for Katie Devine's departure or any financial targets for the division.
The players
Carlos Andres-Luna
Andres-Luna is a Mars executive who previously led Royal Canin's Rapid Growth Markets region and holds degrees from San Pablo CEU University, ESCE Paris, and IESE Business School.
Mars Petcare
Mars Petcare is the pet care division of Mars, Incorporated, which is known for brands spanning food, veterinary diagnostics, and science.
Marc Carena
Marc Carena is President of Mars Petcare, to whom Andres-Luna will report in the new role.
The details
Andres-Luna was selected through an internal promotion, having joined Mars in 2009 after earlier consulting work at Bain & Company and a role at J.P. Morgan Investment Bank. He holds a degree from San Pablo CEU University and ESCE Paris and an MBA from IESE Business School.
Timeline
November 19, 2026: Mars announces Andres-Luna's appointment in a press release dated from Brussels.
January 1, 2027: Andres-Luna starts as Global President of Science & Diagnostics.
Market Landscape
The appointment places a Royal Canin veteran at the head of a diagnostics unit that spans veterinary testing and genomics, a segment where pet care companies are competing for scientific credibility. Mars is building on the Waltham Petcare Science Institute's more than 60 years of pet health research to support that positioning.
Pet owners and veterinary clinics using Antech diagnostics, Vetsource, or Wisdom Panel testing may see continuity in these services under the new division leadership. The change itself does not announce any immediate pricing or product changes.
The takeaway
Leadership transitions in specialized divisions often signal where a company intends to focus its science and diagnostics investment. Watching for strategy updates from the division in the coming months will show whether that focus changes.
Further reading
Explore more executive moves in the People section for context on leadership changes across the industry.



